Clearpoint Neuro Inc CLPT

$10.90 -0.55 (-4.80%)

Valuation

Market cap
349,271,000
Revenue TTM
$36,970,000
Net income TTM
$-25,540,000
PE ratio
0.00
Forward PE
—
Profit margin
-69.08%
Debt to equity
4.66

Trading

Volume
833,200
Avg volume
662,762
Day's range
$10.85 – $11.58
Shares out
30,504,000
Stochastic %K
1%
Beta
1.29
Analysts
Strong Sell
Price target
$23.50

Price

Company profile

ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States. The company offers ClearPoint systems, such as ClearPoint hardware, which includes head fixation frame, computer workstation, and in-room monitor; and ClearPoint disposables, which consist of SmartFrame...

Show more

ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States. The company offers ClearPoint systems, such as ClearPoint hardware, which includes head fixation frame, computer workstation, and in-room monitor; and ClearPoint disposables, which consist of SmartFrame trajectory device, a hand controller and related accessories, and its SmartFlow Neuro cannula. It also provides ClearPoint software, which guides the physician in surgical planning, device alignment, navigation to the target, and procedure monitoring; ClearPoint Prism Neuro laser therapy system to necrotize or coagulate soft tissue; and IRRAflow system, an active fluid exchange platform. In addition, the company offers consulting services to its pharmaceutical and other medical technology partners, such as benchtop testing, preclinical studies, clinical trial support, regulatory consultation, and translation from the preclinical to the clinical setting. It has licenses and collaboration agreements with Koninklijke Philips N.V., UCB Biopharma SRL, Clinical Laserthermia Systems AB, University of California, San Francisco, and NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

Industry
Medical Devices
Sector
Healthcare
Phone
888 287 9109
Website
https://www.clearpointneuro.com
Address
120 S. Sierra Avenue, Suite 100, Solana Beach, United States

Latest news

Stocktwits

NeuroOne_IR Oct 2, 2:14 PM
$NMTC We have shared individual patient stories and clinical experiences across the NeuroOne platform over time. Together, they also help tell a broader story about execution. At Mayo Clinic Florida, physicians reported experience across 25 patients with drug-resistant focal epilepsy treated using the OneRF® Brain Ablation System. We have also shared patient experiences across our brain and trigeminal nerve ablation technologies in different clinical settings. These examples are important not only as individual patient stories, but because they help illustrate that NeuroOne technologies are already being used in real clinical practice today. Combined with published experience and continued activity across clinical centers, they provide another view into the growing use of the platform beyond future development milestones. $CLPT $GMED
0 replies
Twister8 Oct 1, 3:08 PM
$CLPT Joe need another can of Spaghetti? How are the maestro sales?
0 replies
MajorBigBull Sep 30, 5:40 PM 0 replies
NeuroOne_IR Sep 30, 2:31 PM
What does institutional validation look like in practice? Across NeuroOne’s platform, we are seeing that validation take different forms — from leading institutions selecting our StereoCED™ drug delivery technology for research programs, to published clinical experience and patient use across treatment centers. Each of these milestones represents a different stage of execution: technology being selected for research, advancing into active studies, being used in clinical settings, and generating a growing body of real-world experience. Viewed together, they help show how external validation is translating into tangible progress across the NeuroOne platform. $CLPT $GMED $NMTC
1 replies
WonderfulMongoose Sep 29, 8:53 PM
$CLPT LOL at all these big moves off one partner's data.
2 replies
degeneratetrader23 Sep 29, 7:57 PM
$CLPT last time we gapped down on similar volume, the stock had 7 green days in a row.
1 replies
Thinkingman91 Sep 29, 7:50 PM
$CLPT I’m cutting losses here. Had multiple chances to make money and didn’t take them. I’m tired of holding even if I like them.
3 replies
Twister8 Sep 29, 6:49 PM
$CLPT Joe's biggest bet just blew up...how are the drill sales Joe?
0 replies